The University of San Francisco

USF Scholarship: a digital repository @ Gleeson Library |
Geschke Center
Master's Projects

Theses, Dissertations, Capstones and Projects

Winter 12-18-2015

Hepatitis C: A Perspective Through the Social
Ecological Model
Sandra H. Vulis
University of San Francisco, svulis@hotmail.com

Follow this and additional works at: http://repository.usfca.edu/capstone
Recommended Citation
Vulis, Sandra H., "Hepatitis C: A Perspective Through the Social Ecological Model" (2015). Master's Projects. Paper 248.

This Project is brought to you for free and open access by the Theses, Dissertations, Capstones and Projects at USF Scholarship: a digital repository @
Gleeson Library | Geschke Center. It has been accepted for inclusion in Master's Projects by an authorized administrator of USF Scholarship: a digital
repository @ Gleeson Library | Geschke Center. For more information, please contact repository@usfca.edu.

Running head: HCV THROUGH THE ECOLOGICAL MODEL

Hepatitis C:
A Perspective Through the Social Ecological Model

Sandra Vulis, B.S.
MPH Candidate

December 8th, 2015
University of San Francisco
School of Nursing and Health Professions

1

Running head: HCV THROUGH THE ECOLOGICAL MODEL

2

Table of Contents

Table of Contents

2

Introduction

3

Public health problem

4

Social ecological model

5

Fieldwork details

8

Public health significance

10

Conclusion

11

References

14

Appendices:
A
B
C
Competencies

18
19
20
23

Fieldwork reflection

24

Running head: HCV THROUGH THE ECOLOGICAL MODEL
Hepatitis C virus (HCV) is a major global public health problem. The Center for
Disease Control and Prevention (CDC) estimates that the Hepatitis C virus (HCV) affects
3.2 million Americans and 500 million people from a global standpoint (CDC, 2012).
HCV contributes to significant morbidity and mortality with about 1 million deaths due
to liver disease (World Hepatitis Alliance, 2010). Chronic liver disease has origins
ranging from acquired, infectious, toxic and metabolic causes. Long-term consequences
include cancer, cirrhosis (scarring of the liver), and liver failure. Given the substantial
morbidity attributable to HCV-related liver disease, it is necessary to develop an HCVrelated public health plan for the prevention of new HCV infections. The source of HCV
infection includes transfusion of blood or blood products from unscreened donors,
exposure to blood through the use of contaminated and inadequately sterilized
instruments and needles used in medical and holistic medicine, persons who participate in
high-risk sexual practices, or sexual interactions with HCV-infected persons. The relative
contribution of these various sources of infection has not yet been defined with
population-based epidemiological studies. New infections continue to occur and burden
global public health systems.
The aim of this paper is to discuss the prevalence, incidence and burdens of
chronic hepatitis C and to report on the fieldwork project completed at the California
Pacific Medical Center in conjunction with the San Francisco Center for Liver Disease.
Utilizing an ecological framework the role of public health to develop awareness
opportunities about HCV, help patients access and evaluate their treatment options, and
provide support to those newly diagnosed and their families will be examined.
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Public Heath Problem
The hepatitis C virus (HCV) is recognized as a major cause of chronic liver
disease worldwide. Moreover, hepatitis C leads to cirrhosis, which is the most common
cause of chronic liver disease in the United States (Mueller et al., 2009). The World
Health Organization (WHO, 1998) estimates that the prevalence of HCV infection is 2%,
which represents 123 million people worldwide. Additionally, a liver transplant is a
common treatment option for those with chronic liver failure to enhance the quality of
life (WHO, 1998). The CDC predicts that the availability of highly effective antiviral
therapies will significantly reduce the incidence rates to make HCV a rare disease by
2036. Despite those positive trends in treatment options, 10-16% still develop cirrhosis
(Robert et al., 2004). However, the public health problem at hand is the lack of data and
interventions for high-risk groups such as those co-infected with HIV/AIDS (ProescholdBell, 2011). An estimated 1 million people in the United States are diagnosed with both
HIV and HCV with approximately 56,000 new HIV infections occurring each year
(Proeschold-Bell, 2011).
Accurate epidemiological data is the foundation to prevent and control any
infection. Co-morbidities are common especially when diseases share the similar routes
of transmission. Such is the case of HCV and HIV. Modes of transmissions are via blood
and bodily fluids and transmission can occur via multiple portals. Risk of transmission
exists in occupational and perinatal settings, as well as through sexual encounters,
regardless of population or geographic region. One of the cofactors known to accelerate
the progression of HCV among those infected is HIV (Chiao, 2014) (See Appendix A).
The epidemiology of this cofactor is an important area of public health research and
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education. Nevertheless, the HCV-infection population has grown so large, it is now
considered a global endemic, even though it occurs in only a fraction of people.
Social Ecological Model
Education and treatment interventions have been shown to positively influence
behaviors related to chronic disease prevention (Wilson et al., 2006). When treatment
options are publicly demonstrated, those more at-risk are given a reason to get tested.
Public health interventions can be approached using the comprehensive multilevel Social
Ecological Model (SEM). This promising approach is important for those diagnosed with
HCV because HCV prevention and treatment occurs within multiple levels of the health
care system. The SEM is described using five levels that influence health:
1. Intrapersonal-beliefs and characteristics,
2. Interpersonal-relationships and social networks such as spouse,
friends and family
3. Community-experiences and resources,
4. Institutional-rules and regulations concerning healthcare,
5. Policy-structures and environments that impact health.
In general, the SEM suggests that individual behavior and social environments are
related. This model would be beneficial in gaining more insight to target the specific
population of those HCV-infected or at-risk for HIV. Although each level is unique, each
level is capable of impacting one another. Individuals infected with either HCV or both
HIV-HCV can live a long time with their diseases and their care can impact their family
and other relationships, as well as their community establishments, such as liver clinics
and hospitals. Furthermore, the SEM is extremely useful in tailoring a community-based
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intervention to a particular socio-cultural context for people with HIV and HCV that also
includes individual intervention levels (Proeschold-Bell, 2011). For example, many feel
hesitant to discuss their disease status because of cultural factors that fall into place.
Proeschold-Bell et al. (2011) utilized the social ecological model and conducted a
multilevel intervention to improve the knowledge of HCV risk, knowledge of one's own
HCV status, and receipt of HCV education from a medical provider of those infected
with HIV. Their primary target group was people with HIV who already had HCV coinfection or were at risk for HCV. The intervention was conducted at four levels of the
SEM: intrapersonal, interpersonal, community, and institutional. At the individual level,
participants were assigned case management and provided mental health and substance
use counseling and included harm reduction such as reduced and clean needle use. At the
interpersonal level, monthly support groups were offered at 2 sites. At the community
level, health classes were offered to the general public as well as HIV infected persons
who were at risk for HCV infection. A public media campaign was also launched to
inform and educate people about HCV risk, transmission and treatment. At the
institutional level, information technology was changed at HIV clinics that enabled the
creation of a face sheet to be placed on the charts to flag if a patient was tested for HCV,
the test date and results, and whether or not the patient was vaccinated against hepatitis A
or B. In addition medical providers were educated on HIV-HCV co-infection patient
care, HCV treatment, testing, and transmission.
The sample included n = 259 participants of whom data were collected every two
weeks over a two year period. This Interrupted Time Series design enabled the
researchers to collect pre intervention community data and continue throughout the
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intervention period over time. Demographics of the participants included: mean age of
43 years old; 68.3% male; 58.3% African-American; 76% with high school education;
and 24%with a college degree or higher. Patient characteristics were tested systemically
as “covariates” so that only statistically significant covariates were kept in the final
analysis. Data collection methods included face-to-face interviews, which included
questioning participants about their HIV status, whether they knew about HCV risk
behaviors, and history of high-risk sexual encounters. Participants were also asked
whether or not they had been tested for HCV and if they received education on HCV
from their respective provider(s) (Proeschold-Bell et al., 2011).
Results demonstrated that “accurate HCV knowledge among patients with HIV
was higher during the intervention phase than the pre-intervention phase” (p. 8). (See
Appendix B for complete results.) The authors reported that the framework of SEM was a
successful guide and the primary goal was achieved. The HIV-positive population is
increasing in liver-related mortality, which makes HCV prevention and treatment a
significant priority.
HCV prevention can be addressed on multiple levels represented in the social
ecological model and on all levels of prevention—primary, secondary, and tertiary. Liver
transplants would be considered a tertiary prevention that entails interventions on
multiple levels of the SEM such as intrapersonal (the need for individuals to maintain a
healthy lifestyle and resist alcohol and drug consumption), interpersonal (working with
clear communication between discordant couples to reduce transmission, as well as
drumming up social support for liver transplant candidates), and organizational levels
such as transplant organizations to assure the effective and thorough care and selection of
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transplant candidates to guarantee success and efficient use of limited public resources.
Work done in this fieldwork placement was mostly focused on the organizational level of
a transplant center although intrapersonal education and care as well as interpersonal
support was included in the center's scope of practice.
Fieldwork Details
Due to the high volume of patients consistently being diagnosed with various liver
diseases, the primary goal of this fieldwork project conducted at the California Pacific
Medical Center in conjunction with the San Francisco Center for Liver Disease was to
promote and facilitate communication among the team and develop better guidelines for
patient care. This fieldwork experience focused on providing a highly specialized
framework to outpatient registered nurses. The role of the Transplant Specialist was
further developed to enable integration between all team members of the liver and heart
transplant department. In the first 30 days, it was essential to monitor and track the
number of phone calls in order to provide significant patient data of incoming calls.
These calls were due to the elevated number of patients in the hepatology and transplant
program(s). The nurses were not able to provide sufficient care due to the high volume.
Therefore, this fieldwork experience not only provided primary support to the nurses but
also reduced their workload to prevent medical errors while practicing medicine.
All goals were accomplished through activities guided by detailed objectives.
These objectives were organized meticulously as the fieldwork progressed. The first
objective was in correlation with goal one. In order to become familiar with the general
service of this clinic and hospital, it was vital to complete an extensive assessment of
department materials during orientation. This involved arranging several meetings with
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multiple members of the hepatology and transplant department to better understand each
specific individual role. Furthermore, it was necessary to attend and participate in all
department meetings. Observing how each team member worked together helped
understand how patients are commonly organized towards the end result: a healthy
quality of life.
The final learning objective was to implement clinic-based projects aimed at a
non-clinical level. These projects included data collection for compliance with United
Network for Organ Sharing (UNOS), transition patients who are >5 years post-transplant
to primary care and the development of the prior authorization packet for hepatitis C
treatment medications. It was essential to understand how compliance and ethical
considerations were formulated within the hospital policies and procedures; every
protocol is interwoven between numerous pathways. Principally, the hospital and clinic
change their protocols every so often due to federal regulations such as Centers for
Medicaid Services (CMS), United Network for Organ Sharing (UNOS) and Donor
Network West (California’s Organ Procurement Center). Consistently changing protocols
aids to explore risk-benefits as well as ensure safer practices for patients. These
preventive measures are based upon a national data derived from individual and
population-level statistics. The fieldwork project simplified strategies to establish,
enhance and developed the initial role of the Transplant Specialist as an important asset
in the public health prevention segment. (See Appendix B for SMART goals.)
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Public Health Significance
California Pacific Medical Center Department of Liver Transplant is a united
multidisciplinary community consisting of surgeons, transplant hepatologists, social
workers, financial analysts, nutritionists and nurses. This team is “designed” to
encompass all to fundamentally provide the best care and support for all patients’ part of
the program. Each patient in the program starts in the hepatology “phase.” This means
that any patient a part of the hepatology phase is battling a specific liver disease. For
example, hepatitis B, autoimmune hepatitis and hepatitis C are of the most common. If
the patient’s primary hepatologist believes that a patient is “ready” to be evaluated for a
transplant, then the patient is moved into the “evaluation” phase. During evaluation,
patients undergo a series of diagnostic tests, lab work and a mandatory psychosocial
assessment. Additionally, it is a requirement for the patient to have a valid support
person. The support person is also evaluated by a licensed social worker if she or he can
withstand the necessary and complex care for a recently transplanted person. Once a
patient is listed, the patient is placed in the donor “pool” based on MELD score and blood
type. MELD score is defined as: “Model for End Stage Liver Disease.” The MELD score
ranges from 6-40; patients are arranged into either low-MELD (6-20) or high-MELD (2140). Sometimes patients get deactivated because their liver disease has improved even
though they may still be symptomatic.
While the program is highly organized, the public health problem(s) presented
needs continuous time and effort to develop interventions that would be more successful
and efficient. Recently, a successful cure for HCV has been developed. An abundance of
hepatitis C medication orders began to occur in late 2014 when the Federal Drug
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Administration approved the hepatitis C treatment drug, Harvoni. Harvoni is the first
combination pill approved to treat chronic HCV genotype 1 infection (FDA, 2014). It is
also the first approved regimen that does not require administration with interferon or
ribavirin, two FDA-approved drugs also used to treat HCV infection (FDA, 2014). The
efficacy of Harvoni was evaluated and observed in multiple clinical trials involving
patients that were either treatment-naïve or treatment-experienced (Gilead Sciences,
2015). These trials were designed to measure whether or not the virus was detected in the
blood after 12 weeks of treatment. This is known as a “sustained viral response” (SVR).
Due to the miraculous discovery that the medication, Harvoni significantly reduced the
detection of the virus (SVR), the clinic experienced a significantly high increase in the
amount of medications ordered. It is an understatement to note that patients chronically
diagnosed with hepatitis C for over two decades were interested in this revolutionary
medication. Hence, a protocol was implemented to stay as organized as possible. This
protocol added the duty of the Transplant Specialist to respond to these orders in a timely
fashion. The role of the Transplant Specialist expedited HCV orders while adhering to an
established protocol. Although the epidemiological data are limited, other agents awaiting
FDA approval are expanding as part of the advancing public health surveillance and
development of effective treatments to combat HCV.
Conclusion
It is difficult to prevent and control chronic liver disease due to the multiple
contributing factors. Regrettably, there is no vaccine and no post-exposure prophylaxis for
HCV. Many also do not seek care because they don't know they are infected; the incubation
period for HCV can be decades long (Kamal, 2008). Primary prevention tactics should
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include but not be limited to: safer blood transfusions in developing countries, and safer
injection practices in health care and in other settings such as tattoo parlors. Individuals
who are HIV-infected and inject drugs may find it difficult to retain knowledge about HCV
transmission. Data suggest that injecting drug use between intimate partners is a significant
contribution to the occurrence of the hepatitis C infection mostly because those with HCV
who are in intimate relationships often do not disclose their status to their partners (Seear et
al., 2012). Furthermore, unprotected sexual relations between discordant couples increases
transmission rates even more (Seer et al., 2012). The public health community must
address this risk in order to reduce the transmission of HCV.
The need to coordinate efforts for either primary HCV prevention focused on
a specific risk-group or secondary prevention efforts such as the ability of those
infected with HCV to receive effective treatment drugs without delay are both
crucial public health imperatives. Future prevention efforts should include the
development of educational materials that can be posted in a clinic or within the
community to encourage patients to attend classes, get tested and practice safer sex,
especially in those already receiving counseling with HIV. Training HIV providers early
about HCV infection may also be implemented during appointments, as some may never
have had formal medical training on hepatitis in general. Lastly, it may also be wise to
initiate a system-wide electronic medical record for those who pose significant risk when
visiting healthcare providers, or being admitted into hospitals. These strategies can help
minimize incidence of new cases and thus decrease the overall prevalence of HCV.
Reducing incidence of HCV would greatly decrease the need for liver transplants in those
with chronic liver damage and thus save valuable resources that could be utilized for
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primary prevention. These recommendations are consistent from the CDC’s HCV
National Prevention Strategy for Health Professionals (CDC, 2010).
	
  

13

Running head: HCV THROUGH THE ECOLOGICAL MODEL
References
Bramstedti, K & Jabbour, N. (2006). When alcohol abstinence criteria create ethical dilemmas
for the liver transplant team. Journal of Medical Ethics, 32(5): 263-265. Retrieved from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2579412.

Centers for Disease Control and Prevention. (2015). People Who Inject Drugs and Viral
Hepatitis. Retrieved from http://www.cdc.gov/hepatitis/populations/idu.html

Centers for Disease Control and Prevention. (2010). National Hepatitis C Prevention
Strategy: A comprehensive strategy for the prevention and control of hepatitis c
virus infection and its consequences. Retrieved from
http://www.cdc.gov/hepatitis/HCV/Strategy/NatHepCPrevStrategy.htm#summary

Chiao, H, & Frenette, C. (2014). Solid organ transplantation: Little research, big need
for patients with HCV. Retrieved from http://www.healio.com/infectiousdisease/hepatitis-c/news/print/hcv-next/%7B9b9182d3-91d1-4b08-aa109d57b03807eb%7D/solid-organ-transplantation-little-research-big-need-forpatients-with-hcv

Forman, L., Lewis, J, Berlin, J, Feldman, H, & Lucey, M. (2002). The association
between hepatitis c infection and survival after orthotopic liver transplantation.
Gastroenterology, 122(4), 889-896.

14

Running head: HCV THROUGH THE ECOLOGICAL MODEL
Federal Drug Administration. (2014, October 14). FDA approves first combination pill to
treat hepatitis C. Retrieved from
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm418365.ht
ml

Gane, E., Portmann,B, Naoumov, N, Smith, Heather., & Underhill, J. (1996). Long-term
outcome of hepatitis c after liver transplantation. The New England Journal of
Medicine, 334(13), 815-820.

Gilead Sciences. (2015, April 25). Gilead announces results from studies evaluating
Sofosbuvir-based regimens in chronic hepatitis c patients with genotypes 2-5.
Retrieved from, http://www.gilead.com/news/press-releases/2015/4/gileadannounces results-from-studies-evaluating-sofosbuvirbased-regimens-in-chronichepatitis-c-patients-with-genotypes-25

Guirguis, J., Chhatwal, J., Dasarathy, J., Rivas, J., and Nagy, L. (2015). Clinical impact
of alcohol-related cirrhosis in the next decade: Estimates based on current
epidemiological trends in the United States. Alcoholism Clinical and Experimental
Review, 39 (11), 2085-2094.

Hellard, M & Sacks-Davis, R & Gold, J. (2009). Hepatitis c treatment for injection drug
users: a review of the available evidence. Oxford Journal, 49(4): 561-573.
Retrieved from http://cid.oxfordjournals.org/content/49/4/561.long

15

Running head: HCV THROUGH THE ECOLOGICAL MODEL
Lifespan. (2015). Hepatitis C: Life-threatening barriers in access to breakthrough drugs in US.
Retrieved from http://www.sciencedaily.com/releases/2015/06/150629180005.htm

Nair, S. (2012). Management of hepatitis c virus infection in liver transplant recipients.
Journal of Gastroenterology Hepatology, 8(1), 56-59, Retrieved from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277201/
Mueller S, Millonig G, Seitz HK (2009) Alcoholic liver disease and hepatitis C: a
frequently underestimated combination. World J Gastroenterol 15:3462–3471
Proeschold-Bell, R.,Hoeppner,B., Taylor,B., Cohen,S., Blouin, R., Stringfield,B, & Muir,
A. (2011). An interrupted time series evaluation of a hepatitis c intervention for
persons with HIV. AIDS Behaviors, 15(8), 1721-1731
Robert E, Mann RGS, Richard G (2004) The epidemiology of alcoholic liver disease.
NIAAA, Rockville, MD.
Seear, K., Gray, R., Fraser, S., Treloar, C., Bryant, J., & Brener, L. (2012). Rethinking
safety and fidelity: The Role of love and intimacy in hepatitis C transmission and
prevention. Health Sociology Review, 21(3), 272-286

Shepard, C., Finelli, L, & Alter, M. (2005). Global epidemiology of hepatitis c virus
infection. The Lancet Infectious Diseases, 5(9), 558-567

16

Running head: HCV THROUGH THE ECOLOGICAL MODEL
Slomka, J., Quill, B., Kendrick, M, & Llyod, L. (2008). Professionalism and ethics in the
public health curriculum. Public Health Reports, 123(2), 27-35

Wapner, J. (2014, September 1). A long, difficult and costly research effort gives doctors
a new cure for hepatitis C. Retrieved from
http://www.scientificamerican.com/article/we-now-have-the-cure-for-hepatitis-cbut-can-we-afford-it/

World Health Organization. (1999). Global database on blood safety summary report
1998–1999. Retrieved from,
http://www.who.int/bloodsafety/global_database/en/SumRep_Eng lish.pdf

Wilson, FL. (2006). Can easy-to-read immunization information increase knowledge in
urban low-income mothers? Journal of Pediatric Nursing, 21(1), 4-12

17

Running head: HCV THROUGH THE ECOLOGICAL MODEL
Appendix A
HCV Progression of Disease

Source: Chiao, H., & Frenette, C. (2014). Solid Organ Transplantation: Little Research, Big
Need for Patients with HCV
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Appendix B
Social Ecological Model
Level
of influence
Intrapersonal

Definition
•

Individual behaviors

Example
•
•
•

Substance abuse
counseling
HCV antiviral therapy
Sexual abstinence

Interpersonal

•
•
•
•

Family
Friends
Co-workers
Neighbors

•

Support groups for those in
close relationships with
infected populations

Organizational Community

•
•
•
•
•

Neighborhoods
Churches
County jails
Media
Homeless shelters

•

Free health classes to the
available general public
Training HIV educators on
HCV
Public health campaigns
such as websites that offers
locations of free test sites

•

Laws - both local,
state and federal

•
•
•

Public Policy*

•
•

More public awareness
Free testing sites
Government assistance
programs for cost-effective
treatment

Source: Proeschold-Bell, R.,Hoeppner,B., Taylor,B., Cohen,S., Blouin, R., Stringfield,B,
& Muir, A. (2011). An interrupted time series evaluation of a hepatitis c intervention for
persons with HIV. AIDS Behaviors, 15(8), 1721-1731
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Appendix C
SMART Goals
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Appendix C continued
SMART Goals
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Appendix C continued
SMART Goals
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Competencies Addressed
Multiple competencies part of USF’s MPH Program was addressed throughout
this fieldwork experience:
1. Assess, monitor, and review the health status of populations and
their related determinants of health and illness
2. Identify and prioritize the key dimensions of a public health
problem by critically assessing public health literature utilizing
both quantitative and qualitative sources.
3. Develop public health programs and strategies responsive to the
diverse cultural values and traditions of the communities being
4. Identify and apply ethical, moral, and legal principles in all
aspects of public health practice.
Competency #1 was continuously observed; reviewing data related to patients
diagnosed with chronic liver disease as well as the social determinants discussed during
the transplant evaluation phase of the hepatology program. Observing determinants such
as, a history of drug and alcohol use was vital towards understanding the population at
hand. Furthermore, competency #2 was achieved because of the management of
quantitative and qualitative data consistently being investigated with UNOS compliance.
Reviewing patients’ charts for compliance was broadly towards successful validation of
the UNOS forms. Moreover, patients in process of starting HCV treatment are required
compliance; maintaining all blood work and diagnostic imaging tests.
Developing public health programs and strategies based on diverse cultural values
was a unique yet critical competency. For patient’s diagnosed with HCV, the treatment
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plan was based specifically on genotype (See Appendix B). Genotype bases the
physician’s care plan because of the patient’s geographical origin. This competency was
achieved through orders directed from the providers; it was clear that genetics make it
critical regarding the “design” of treatment. Lastly, competency #4 was analytical in the
development of protocol(s). Emerging liver diseases involves professionals to ask, “What
is the right thing to say or do? Ethical values have always provided a foundation for the
public health practice. The Transplant Specialist role delivered ethnical questioning, yet
positively expanded the relationship(s) between patients and the clinic. Developing this
role was crucial because of patient volume and the need to improve patient care was
obvious. Conceptualizing public health within the field of clinical medicine will involve
challenges along the way, but the prevention of disease, promotion of health and
development of policy will increase in scope and sophistication (Slomka et al, 2008).
Reflection
To conclude, this fieldwork experience was an excellent professional learning
experience. California Pacific Medical Center, in conjunction with the San Francisco
Center for Liver Disease provide a sufficient environment that is supportive, innovating
and challenging in the intricate world of healthcare. Meetings, presentations, series
lecture, conferences and personal one-on-one interviews expanded my knowledge
heavily. The two preceptors have exceeded all my expectations through example:
coaching, training, and providing detailed answers to answers. As an MPH candidate, I
was able to witness first hand cases with these two preceptors or registered nurses. This
experience was far more interesting because I witnessed a management side and a clinical
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nursing side. Further, I was able to utilize my leadership skills by training other members
of the team with my past experience as a pharmacy technician.
Although the majority of my role was to establish a HCV protocol, it was truly
eye opening to witness a regular person get diagnosed with chronic end stage liver
disease, go through the process of being listed for a new organ and then suddenly, get
transplanted as if the disease never occurred. It is a miraculous how far medicine and
technology improved the last decade and as a MPH, I intend to be a part of this revolution
as CPMC’s opens new hospital doors in 2020. I intend to promote HCV awareness,
advocacy for organ donation while utilizing the skills I’ve achieved in my epidemiology,
advanced biostatistics, communication for healthy communication, social justice and
policy and this fieldwork experience. My skills will continue to improve and as a
Transplant Specialist, I believe that improving patient lives is by far the most important.
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